Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea

PHASE2UnknownINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

May 17, 2019

Study Completion Date

August 17, 2019

Conditions
Papulopustular Rosacea
Interventions
DRUG

minocycline topical gel

Once daily administration of BPX-04 minocycline gel for 12 weeks

DRUG

topical gel vehicle

Once daily administration of BPX-04 gel vehicle for 12 weeks

Trial Locations (12)

19103

Study Center, Philadelphia

27262

Study Center, High Point

33027

Study Center, Miramar

33175

Study Center, Miami

64506

Study Center, Saint Joseph

70115

Study Center, New Orleans

70809

Study Center, Baton Rouge

78213

Study Center, San Antonio

78759

Study Center, Austin

92807

Study Center, Anaheim Hills

02135

Study Center, Needham

07960

Study Center, Morristown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioPharmX, Inc.

INDUSTRY